See more : ISDN Holdings Limited (I07.SI) Income Statement Analysis – Financial Results
Complete financial analysis of One World Products, Inc. (OWPC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of One World Products, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Jiangsu Olive Sensors High-Tech Co., Ltd. (300507.SZ) Income Statement Analysis – Financial Results
- Petgo Corporation (7140.T) Income Statement Analysis – Financial Results
- Stockmann Oyj Abp (STOCKA.HE) Income Statement Analysis – Financial Results
- Tarai Foods Limited (TARAI.BO) Income Statement Analysis – Financial Results
- NewtekOne, Inc. 8.625% Fixed Rate Senior Notes due 2029 (NEWTH) Income Statement Analysis – Financial Results
One World Products, Inc. (OWPC)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.oneworldproducts.com
About One World Products, Inc.
One World Products, Inc. produces and sells raw cannabis and hemp products worldwide. It also focuses on cultivating, processing, and supplying of crude cannabis oil, distillate, and isolate. The company was formerly known as One World Pharma, Inc. and changed its name to One World Products, Inc. in November 2021. One World Products, Inc. is headquartered in Las Vegas, Nevada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 7.59K | 125.66K | 38.26K | 59.57K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 173.12K | 300.76K | 19.74K | 104.73K | 19.67K | 1.96K | 0.00 | 0.00 | 3.60K | 0.00 |
Gross Profit | -165.53K | -175.10K | 18.52K | -45.16K | -19.67K | -1.96K | 0.00 | 0.00 | -3.60K | 0.00 |
Gross Profit Ratio | -2,181.22% | -139.34% | 48.40% | -75.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 1.88M | 2.02M | 3.21M | 7.84M | 5.72M | 26.96K | 56.88K | 36.66K | 22.90K | 420.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 1.88M | 2.02M | 3.21M | 7.84M | 5.72M | 26.96K | 56.88K | 36.66K | 22.90K | 420.00 |
Other Expenses | 34.27K | 42.29K | 40.32K | 33.61K | 102.00K | 0.00 | 0.00 | 14.77K | 0.00 | 0.00 |
Operating Expenses | 1.92M | 2.06M | 3.25M | 7.87M | 5.72M | 26.96K | 56.88K | 36.66K | 22.90K | 420.00 |
Cost & Expenses | 2.09M | 2.36M | 3.27M | 7.98M | 5.72M | 26.96K | 56.88K | 36.66K | 26.50K | 420.00 |
Interest Income | 7.00 | 38.00 | 2.36K | 47.59K | 4.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 308.74K | 956.86K | 511.13K | 47.59K | 382.58K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 34.27K | 157.19K | 127.60K | 76.75K | 19.67K | 1.96K | 186.06K | 22.82K | 0.00 | 0.00 |
EBITDA | -3.58M | -2.24M | -3.21M | -7.88M | -5.80M | -1.87M | -56.88K | -21.89K | -26.50K | -420.00 |
EBITDA Ratio | -47,119.82% | -1,745.01% | -8,262.66% | -13,235.22% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -2.08M | -2.24M | -3.23M | -7.92M | -5.72M | -26.96K | -56.88K | -36.66K | -26.50K | -420.00 |
Operating Income Ratio | -27,419.57% | -1,779.48% | -8,444.76% | -13,291.65% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -1.87M | -823.34K | -553.26K | -47.59K | -386.67K | -1.93M | 0.00 | 14.77K | 0.00 | 0.00 |
Income Before Tax | -3.95M | -3.06M | -3.78M | -7.97M | -6.21M | -26.96K | -56.88K | -21.89K | -26.50K | -420.00 |
Income Before Tax Ratio | -52,092.78% | -2,434.69% | -9,890.66% | -13,371.54% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 1.78M | 538.13K | 47.59K | 382.58K | -161.14K | -186.06K | -14.77K | 0.00 | 0.00 |
Net Income | -3.95M | -4.84M | -4.32M | -8.01M | -6.59M | -26.96K | -56.88K | -21.89K | -26.50K | -420.00 |
Net Income Ratio | -52,092.78% | -3,851.34% | -11,297.02% | -13,451.44% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -0.05 | -0.07 | -0.07 | -0.16 | -0.16 | -0.02 | -0.04 | -0.02 | -0.03 | 0.00 |
EPS Diluted | -0.05 | -0.07 | -0.07 | -0.16 | -0.16 | -0.02 | -0.04 | -0.02 | -0.03 | 0.00 |
Weighted Avg Shares Out | 73.33M | 66.19M | 60.60M | 48.83M | 41.09M | 1.32M | 1.32M | 1.32M | 1.06M | 1.06M |
Weighted Avg Shares Out (Dil) | 73.33M | 66.19M | 60.60M | 48.83M | 41.09M | 1.32M | 1.32M | 1.32M | 1.06M | 1.06M |
Licensed Cannabis and Hemp Producer One World Pharma Engages CORE IR for Investor Relations, Public Relations and Shareholder Communications Services
Emerging Markets Report: Small Wonders
NBA Legend John Salley Joins One World Pharma's Board Of Advisors
Emerging Markets Report: The Game Changer
Isiah Thomas Invests $3M Into Cannabis Co. One World Pharma
Isiah Thomas Releases Letter to One World Pharma Shareholders
One World's Dr. Kenneth Perego Joins Montel Williams for Blunt Discussion
Source: https://incomestatements.info
Category: Stock Reports